on March 14, 2013 |
Permalink
Topics: Oncology, Service Lines, Accountable Care, Market Trends, Strategy, Service Line Growth, Volume Growth
Deirdre Fuller, Oncology Roundtable
Didn’t make it to our 2012 National Meeting series? Don’t worry. We’re delivering our research again as a series of webconferences. During one recent webconference, “The New Rules of Oncology Service Line Growth, Part I,” we asked participants if their cancer programs had any value-based (non-fee-for-service) contracts with commercial payers. Surprisingly, 22% of respondents indicated that their cancer program is involved in either a pay-for-performance, shared savings, or episode-based payment contract.
Continue reading:
Is your cancer program prepared for value-based reimbursement?
Lindsay Conway on October 23, 2012 |
Permalink
Topics: Oncology, Service Lines, Radiation Therapy, Capital Planning, Finance, Academic Medical Centers, Strategy, Technology Assessment, Planning
In case you missed it, our colleagues at Technology Insights posted a new article on their blog this week examing the proliferation of multiple proton therapy providers in single markets.
View their analysis of the changing dynamics of proton patient capture and the potential effects of proton market proliferation on provider institutions included below to learn more.
Chris Pericak and Dave Gaffin, Technology Insights
A local news outlet in West Sussex, UK, recently released an article titled "New Factory to Produce Proton Therapy Systems", conjuring images of factory workers piecing widgets together in a systematic fashion that would make Henry Ford proud.
A closer read, however, reveals that the article is referring to UK-based Tesla Engineering, which makes superconducting magnets that play a role in bringing new small-scale proton therapy models to market. The construction of this new factory reflects a proton therapy supply chain that is readying itself for market proliferation of this technology.
Continue reading:
In case you missed it: Proton therapy on an assembly line?
on October 18, 2012 |
Permalink
Topics: Outcomes, Quality, Performance Improvement, Oncology, Service Lines, Accountable Care, Market Trends, Strategy
Deirdre Fuller, Oncology Roundtable
New American Society of Clinical Oncology (ASCO) resources aim to help oncology providers address tobacco use by cancer patients and subsequently improve patient outcomes.
Tobacco use complicates treatment
Tobacco use is known to negatively impact overall quality of life. Additionally, a growing amount of evidence suggests that tobacco use can complicate several of cancer treatments, including:
- Radiation therapy
- Chemotherapy
- Surgery
Continue reading:
ASCO resources help cancer providers address tobacco use
